Options for first line therapy of Hodgkin lymphoma

por Longley, Jemma, Johnson, Peter W.M.
Publicado 2019

Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches—Focus on EZH2-Targeted Drugs

por Longley, Jemma, Johnson, Peter W. M.
Publicado 2021

Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Stra...

por Savva, Constantinos, Copson, Ellen, Johnson, Peter W. M., Cutress, Ramsey I., Beers, Stephen A.
Publicado 2023

Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial

por Johnson, Peter W. M., Balasubramanian, Sriram, Hodkinson, Brendan, Shreeve, S. Martin, Sun, Steven, Srinivasan, Srimathi, Steele, Andrew J., Vermeulen, Jessica, Sehn, Laurie H., Wilson, Wyndham H.
Publicado 2023

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

por Lim, Sean H, Campbell, Nicola, Johnson, Marina, Joseph-Pietras, Debora, Collins, Graham P, O'Callaghan, Ann, Fox, Christopher P, Ahearne, Matthew, Johnson, Peter W M, Goldblatt, David, Davies, Andrew J
Publicado 2021

Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma

por Birts, Charles N., Savva, Constantinos, Laversin, Stéphanie A., Lefas, Alicia, Krishnan, Jamie, Schapira, Aron, Ashton-Key, Margaret, Crispin, Max, Johnson, Peter W. M., Blaydes, Jeremy P., Copson, Ellen, Cutress, Ramsey I., Beers, Stephen A.
Publicado 2022

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial

por Lim, Sean H., Linton, Kim M., Collins, Graham P., Dhondt, Joke, Caddy, Joshua, Rossiter, Liz, Vadher, Karan, Fines, Keira, Rogers, Laura E., Fernando, Diana, Stanton, Louise, Davies, Andrew J., Johnson, Peter W. M., Griffiths, Gareth
Publicado 2018

Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

por Anderson, Richard A, Remedios, Rachel, Kirkwood, Amy A, Patrick, Pip, Stevens, Linsey, Clifton-Hadley, Laura, Roberts, Tom, Hatton, Chris, Kalakonda, Nagesh, Milligan, Don W, McKay, Pam, Rowntree, Clare, Scott, Fiona M, Johnson, Peter W M
Publicado 2018

Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking

por Turaj, Anna H., Cox, Kerry L., Penfold, Christine A., French, Ruth R., Mockridge, C. Ian, Willoughby, Jane E., Tutt, Alison L., Griffiths, Jordana, Johnson, Peter W. M., Glennie, Martin J., Levy, Ronald, Cragg, Mark S., Lim, Sean H.
Publicado 2018

XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression

por Fisher, Jack G., Doyle, Amber D. P., Graham, Lara V., Sonar, Shreyanshi, Sale, Ben, Henderson, Isla, Del Rio, Luis, Johnson, Peter W. M., Landesman, Yosef, Cragg, Mark S., Forconi, Francesco, Walker, Christopher J., Khakoo, Salim. I., Blunt, Matthew D.
Publicado 2023

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

por Davies, John R., Hilton, Laura K., Jiang, Aixiang, Barrans, Sharon, Burton, Catherine, Johnson, Peter W. M., Davies, Andrew J., Du, Ming-Qing, Tooze, Reuben, Cucco, Francesco, Care, Matthew A., Morin, Ryan D., Steidl, Christian, Sha, Chulin, Westhead, David R., Scott, David W.
Publicado 2023

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

por Hippisley-Cox, Julia, Coupland, Carol AC, Mehta, Nisha, Keogh, Ruth H, Diaz-Ordaz, Karla, Khunti, Kamlesh, Lyons, Ronan A, Kee, Frank, Sheikh, Aziz, Rahman, Shamim, Valabhji, Jonathan, Harrison, Ewen M, Sellen, Peter, Haq, Nazmus, Semple, Malcolm G, Johnson, Peter W M, Hayward, Andrew, Nguyen-Van-Tam, Jonathan S
Publicado 2021

Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies

por White, Ann L., Chan, H.T. Claude, French, Ruth R., Willoughby, Jane, Mockridge, C. Ian, Roghanian, Ali, Penfold, Christine A., Booth, Steven G., Dodhy, Ali, Polak, Marta E., Potter, Elizabeth A., Ardern-Jones, Michael R., Verbeek, J. Sjef, Johnson, Peter W.M., Al-Shamkhani, Aymen, Cragg, Mark S., Beers, Stephen A., Glennie, Martin J.
Publicado 2015

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

por Sha, Chulin, Barrans, Sharon, Cucco, Francesco, Bentley, Michael A., Care, Matthew A., Cummin, Thomas, Kennedy, Hannah, Thompson, Joe S., Uddin, Rahman, Worrillow, Lisa, Chalkley, Rebecca, van Hoppe, Moniek, Ahmed, Sophia, Maishman, Tom, Caddy, Josh, Schuh, Anna, Mamot, Christoph, Burton, Catherine, Tooze, Reuben, Davies, Andrew, Du, Ming-Qing, Johnson, Peter W.M., Westhead, David R.
Publicado 2019

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

por Davies, Andrew J., Barrans, Sharon, Stanton, Louise, Caddy, Josh, Wilding, Sam, Saunders, Geoff, Mamot, Christoph, Novak, Urban, McMillan, Andrew, Fields, Paul, Collins, Graham P., Stephens, Richard, Cucco, Francesco, Sha, Chulin, van Hoppe, Moniek, Tooze, Reuben, Davies, John R., Griffiths, Gareth, Schuh, Anna, Burton, Catherine, Westhead, David R., Du, Ming-Qing, Johnson, Peter W.M.
Publicado 2023

Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit

por Cucco, Francesco, Barrans, Sharon, Sha, Chulin, Clipson, Alexandra, Crouch, Simon, Dobson, Rachel, Chen, Zi, Thompson, Joe Sneath, Care, Matthew A., Cummin, Thomas, Caddy, Josh, Liu, Hongxiang, Robinson, Anne, Schuh, Anna, Fitzgibbon, Jude, Painter, Daniel, Smith, Alexandra, Roman, Eve, Tooze, Reuben, Burton, Catherine, Davies, Andrew J., Westhead, David R., Johnson, Peter W. M., Du, Ming-Qing
Publicado 2019

The prognosis of MYC translocation positive diffuse large B‐cell lymphoma depends on the second hit

por Clipson, Alexandra, Barrans, Sharon, Zeng, Naiyan, Crouch, Simon, Grigoropoulos, Nicholas F, Liu, Hongxiang, Kocialkowski, Sylvia, Wang, Ming, Huang, Yuanxue, Worrillow, Lisa, Goodlad, John, Buxton, Jenny, Neat, Michael, Fields, Paul, Wilkins, Bridget, Grant, John W, Wright, Penny, EI‐Daly, Hesham, Follows, George A, Roman, Eve, Watkins, A James, Johnson, Peter W M, Jack, Andrew, Du, Ming‐Qing
Publicado 2015

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial

por Davies, Andrew, Cummin, Thomas E, Barrans, Sharon, Maishman, Tom, Mamot, Christoph, Novak, Urban, Caddy, Josh, Stanton, Louise, Kazmi-Stokes, Shamim, McMillan, Andrew, Fields, Paul, Pocock, Christopher, Collins, Graham P, Stephens, Richard, Cucco, Francesco, Clipson, Alexandra, Sha, Chulin, Tooze, Reuben, Care, Matthew A, Griffiths, Gareth, Du, Ming-Qing, Westhead, David R, Burton, Catherine, Johnson, Peter W M
Publicado 2019

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia

por Smith, Lindsay D., Minton, Annabel R., Blunt, Matthew D., Karydis, Laura I., Dutton, David A., Rogers-Broadway, Karly-Rai, Dobson, Rachel, Liu, Rena, Norster, Faith, Hogg, Elizabeth, Ashton-Key, Margaret, Strefford, Jonathan C., Jia, Li, Efremov, Dimitar G., Helgason, G. Vignir, Johnson, Peter W. M., Stevenson, Freda K., Forconi, Francesco, Cragg, Mark S., Tumbarello, David A., Packham, Graham, Steele, Andrew J.
Publicado 2019

Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment

por Turaj, Anna H., Hussain, Khiyam, Cox, Kerry L., Rose-Zerilli, Matthew J.J., Testa, James, Dahal, Lekh N., Chan, H.T. Claude, James, Sonya, Field, Vikki L., Carter, Matthew J., Kim, Hyung J., West, Jonathan J., Thomas, Lawrence J., He, Li-Zhen, Keler, Tibor, Johnson, Peter W.M., Al-Shamkhani, Aymen, Thirdborough, Stephen M., Beers, Stephen A., Cragg, Mark S., Glennie, Martin J., Lim, Sean H.
Publicado 2017